HCID 86693525, compound → HCID 86693561, compound

HRID 575487Notes

Reaction equation

HRID 575487 reaction equation
I[C:2]1[CH:20]=[CH:19][C:5]2[O:6][CH2:7][C:8]([F:18])([F:17])[C:9]3[N:10]([N:11]=[C:12]([C:14]([NH2:16])=[O:15])[CH:13]=3)[C:4]=2[CH:3]=1.[N:21]1[CH:26]=[CH:25][CH:24]=[C:23]([C@:27]([OH:31])([C:29]#[CH:30])[CH3:28])[N:22]=1>>[F:17][C:8]1([F:18])[CH2:7][O:6][C:5]2[CH:19]=[CH:20][C:2]([C:30]#[C:29][C@@:27]([OH:31])([C:23]3[N:22]=[N:21][CH:26]=[CH:25][CH:24]=3)[CH3:28])=[CH:3][C:4]=2[N:10]2[N:11]=[C:12]([C:14]([NH2:16])=[O:15])[CH:13]=[C:9]12

Participants

3

Reactant 2

HCID 86693525HCID 86693525, compoundHCID 86693562HCID 86693562, compound

Product 1

HCID 86693561HCID 86693561, compound

Procedure

Similar to as described in General Procedure G, 9-iodo-4,4-difluoro-4,5-dihydrobenzo[b]pyrazolo[1,5-d][1,4]oxazepine-2-carboxamide was reacted with (R)-2-(pyridazin-3-yl)but-3-yn-2-ol to give a mixture of titled compound after purification by prep HPLC.

Workup

  1. customto give

Sources & evidence

ORD record
ord-6f6287fe06db4a02a7414b04c69eee4b
Source dataset
uspto-grants-2015_05
Patent number
US09034866B2

Reaction notes

Loading…